TOP - Daily
Brown University researchers show throat and vocal cords are better protected when heartburn is treated with antacids. Read More ›
A new prostate cancer treatment drug, Xofigo (radium Ra 223 dichloride), has been approved by the FDA for use in men with symptomatic late-stage castration-resistant prostate cancer that has metastasized only to bones. Read More ›
In the quest for a diagnostic test for pancreatic cancer, a study team, which included investigators from Mayo Clinic in Minnesota and Florida, analyzed pancreatic secretions and discovered a molecular marker associated with pancreatic cancer. Read More ›
Researchers from University of Michigan Health System (UMHS) compared central venous catheters (CVCs) with peripherally inserted central catheters (PICCs) and discovered that the risk of dangerous blood clots doubled with the use of PICCs, especially among ICU and cancer patients. Read More ›
In a comprehensive investigation involving decades of published studies, Mayo Clinic researchers have determined that patients with inflammatory bowel disease (IBD) are at a 37% greater risk for melanoma. Read More ›
Results from a study by the gastroenterologists at Arizona Digestive Health in Phoenix, AZ, that were presented at Digestive Disease Week show that patient use of a smartphone app significantly improves colonoscopy preparation. Read More ›
According to a recent analysis by Tufts Center for the Study of Drug Development (CSDD) researchers, clinical success rates for new cancer drugs increased from 9.9% in the mid-1990s to 19.8% in the early 2000s. Read More ›
A novel study by researchers at Women’s College Hospital showed that Metformin may not increase survival rates in older patients with breast cancer and diabetes as previous research suggests. Read More ›
Researchers at the Perelman School of Medicine at the University of Pennsylvania isolated 4 new genetic markers correlated with an increased testicular cancer risk. Read More ›
When compared with screen film mammography and digital direct radiography (DR), computed radiography (CR) is significantly less effective at detecting breast cancer tumors, according to a recent study by Cancer Care Ontario (CCO) researchers. Read More ›